Dr Hilary explains benefit of arthritis drugs tocilizumab and sarilumab When you subscribe we will use the information you provide to send you these newsletters.Sometimes they’ll include recommendations for other related newsletters or services we offer.Our Privacy Notice explains more…
Read More
New Arthritic Knee Pain Treatment Can Lessen Pain Without Surgery
A nonsurgical, minimally invasive treatment effectively provides pain relief both immediately and in the long term. Patients usually go home the same day after a short post-operative observation after undergoing genicular artery embolization or GAE. By reducing inflammation, researchers found…
Read More
Researchers identify inflammatory mechanism related to bone damage in rheumatoid arthritis
In a study aimed at investigating the mechanism responsible for exacerbating rheumatoid arthritis in smokers, researchers at the Center for Research on Inflammatory Diseases (CRID), linked to the University of São Paulo (USP) in Brazil, discovered a novel path in…
Read More
Nearly 20% of Lupus Patients Have Severe Infection in First Decade After Diagnosis
People with systemic lupus erythematosus (SLE) experienced significantly higher rates of first severe infections, a higher number of severe infections overall, and greater infection-related mortality, compared with controls, based on data from a population-based cohort study of more than 30,000…
Read More
Risk for rheumatoid arthritis reduced for patients with T2DM
(HealthDay)—Patients with type 2 diabetes mellitus (T2DM) have a reduced risk for rheumatoid arthritis (RA), which may be due to statin use, according to a study published online Feb. 16 in Rheumatology. Dawit T. Zemedikun, Ph.D., from the University of…
Read More
Naprosyn SR
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. NAPROSYN SR® pronounced nap-row-sin S-R contains the active ingredient naproxen Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about NAPROSYN SR…
Read More
APOTEX-Pantoprazole
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APOTEX- PANTOPRAZOLE TABLETS Contains the active ingredient, pantoprazole (as sodium sesquihydrate) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about pantoprazole….
Read More
Apohealth Anti-inflammatory pain relief tablets
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APOHEALTH ANTI-INFLAMMATORY PAIN RELIEF TABLETS diclofenac sodium Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Apohealth Anti-Inflammatory Pain Relief tablets….
Read More
Brenzys
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. BRENZYS® Solution for Injection (pre-filled syringe); Solution for Injection (Auto-injector) Each syringe or auto-injector contains etanercept 50 mg Consumer Medicine Information What is in this leaflet This…
Read More